Tamara Kaplan, an MS specialist at Harvard Medical School, and Michael Barnett, a consultant neurologist from Sydney, dive deep into the latest guidelines on disease-modifying treatments for multiple sclerosis. They discuss the evolution and importance of these therapies, emphasizing early intervention. The duo also navigates the complexities of individualized treatment approaches, including safety during pregnancy and the challenges posed by varying healthcare systems. Case studies illustrate the necessity for personalized care in MS management, highlighting a global perspective on the issue.
